Momenta Phamaceuticals, Inc. (MNTA) Posts Surprise Q1 Loss

Momenta Phamaceuticals, Inc. (NASDAQ: MNTA) reported Q1 EPS of ($0.10), $0.31 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $24.2 million versus the consensus estimate of $37.38 million.

For earnings history and earnings-related data on Momenta Phamaceuticals, Inc. (MNTA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
• XP Inc eyes US banking license as next business step